Assessment of Effective Anti-TB Regimens and Adverse Outcomes Related Risk Factors in the Elderly and Senile-Aged TB Patients

References

• Zhang H, Zhao YL. Strengthen multi-sectoral cooperation mechanism to further promote the tuberculosis prevention and control in China. Chin J Antituberculosis. 2022;44(2):115–119.
   Google Scholar
• World Health Organization. Global Tuberculosis Report 2022. World Health Organization; 2022.
   Google Scholar
• Li XZ. Diagnosis and treatment status and progress of senile tuberculosis. China Health Industry. 2016;13(33):183–185.
   Google Scholar
• Tang SJ, Gao W. Clinical Tuberculosis. Vol. 774. Beijing: People’s Medical Publishing House; 2019:804–807.
   Google Scholar
• Caraux-Paz P, Diamantis S, de Wazières B, et al. Tuberculosis in the elderly. J Clin Med. 2021;10(24):5888. doi:10.3390/jcm10245888
   PubMed Web of Science ®Google Scholar
• Bansal A, Arora S. Mdr tuberculosis in elderly. Indian J Tuberculosis. 2022;69:S267–S271. doi:10.1016/j.ijtb.2022.10.018
   PubMedGoogle Scholar
• Yang XM, Liu ZD, Zhang ZJ, et al. Clinical characteristics and the treatment of traditional Chinese medicine in senile pulmonary tuberculosis patients. J Tuberculosis Lung Health. 2018;7(3):213–215.
   Google Scholar
• Xi Y, Tang J, Qiao RJ, et al. Investigation of drug resistance status and risk factors of multidrug-resistance in 249 aged pulmonary tuberculosis patients. Chin J Antituberculosis. 2021;43(6):636–641.
   Google Scholar
• Abbara A, Collin SM, Kon OM, et al. Time to diagnosis of tuberculosis is greater in older patients: a retrospective cohort review. ERJ Open Res. 2019;5(4):00228–02018. doi:10.1183/23120541.00228-2018
   PubMedGoogle Scholar
• Moure R, Muñoz L, Torres M, et al. Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol. 2011;49(3):1137–1139.
   PubMed Web of Science ®Google Scholar
• Lin Y, Tan SY, Peng DH, et al. The diagnostic value of tuberculosis infection T cell spot test and Xpert Mtb/RIF detection technology in elderly pulmonary tuberculosis. J Clin Pulmonary Med. 2019;24(2):199–204.
   Google Scholar
• Fu LJ, Wang YS, Zhu WL, et al. Consultation delay and influencing factors among pulmonary tuberculosis patients in Huzhou City from 2008 to 2018. Consultation delay and influencing factors among pulmonary tuberculosis patients in Huzhou City from 2008 to 2018. Chin J Dis Control. 2021;25(2):235–239.
   Google Scholar
• World Health Organization. China country assessment report on ageing and health[M]. World Health Organization; 2015.
   Google Scholar
• Wang Y. The Fifth National Sampling Survey of Tuberculosis Epidemiology. Beijing: Military Medical Science Press; 2011:1–7.
   Google Scholar
• Liu K, Xie Z, Xie B, et al. Bridging the gap in end tuberculosis targets in the elderly population in Eastern China: observational study from 2015 to 2020. JMIR Public Health Surveill. 2022;8(7):e39142. doi:10.2196/39142
   PubMedGoogle Scholar
• Murali S, Krishnamoorthy Y, Knudsen S, et al. Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India. PLoS One. 2021;16(8):e0256773. doi:10.1371/journal.pone.0256773
   PubMed Web of Science ®Google Scholar
• Touré NO, Dia Kane Y, Diatta A, et al. Tuberculose du sujet âgé [Tuberculosis in elderly persons]. Rev Mal Respir. 2010;27(9):1062–1068. doi:10.1016/j.rmr.2010.04.017
   PubMed Web of Science ®Google Scholar
• Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One. 2012;7(10):e46502. doi:10.1371/journal.pone.0046502
   PubMed Web of Science ®Google Scholar
• Guthmann J-P. Les issues de traitement des tuberculoses sensibles déclarées en France, 2008–2014/Treatment outcome of non-resistant tuberculosis cases reported in France, 2008–2014. Bull Epidémiol Hebd. 2018;10:6–7.
   Google Scholar
• Guthmann JP, Léon L, Antoine D, Lévy-Bruhl D. Tuberculosis treatment outcomes of notified cases: trends and determinants of potential unfavourable outcome, France, 2008 to 2014. Euro Surveill. 2020;25(4):1900191. doi:10.2807/1560-7917.ES.2020.25.4.1900191
   PubMedGoogle Scholar
• Aurora H, Kapoor S. Determinants of lost to follow up during treatment among tuberculosis patients in Delhi. Int J Med Res Health Sci. 2016;5:145–152.
   Google Scholar
• Yang D, Wen J, Liu NQ, et al. Factors affecting treatment outcomes of pulmonary tuberculosis in Xinjiang Uygur population. Chin General Pract. 2019;22(12):1413–1418.
   Google Scholar
• Sharareh R, Niakan K, Mahshid N, et al. A logistic regression model to predict high risk patients to fail in tuberculosis treatment course completion. IAENG Int J Appl Math. 2010;40:102–107.
   Google Scholar
• Huang JY, Zhong Q, Zhou L, et al. Meta-analysis of risk factors on pulmonary tuberculosis treatment failure in China. Chin J Dis Control Prevent. 2014;18:102–107.
   Google Scholar
• Xie Y, Han J, Yu WL, et al. Analysis of the effect of short-range supervision on anti-tuberculosis treatment and the risk factors of death in patients with tuberculosis in Tianjin. Public Health China. 2020;36:126–129.
   Google Scholar
• Pratt RH, Winston CA, Kammerer JS, Armstrong LR. Tuberculosis in older adults in the United States, 1993–2008. J Am Geriatr Soc. 2011;59(5):851–857. doi:10.1111/j.1532-5415.2011.03369.x
   PubMed Web of Science ®Google Scholar
• Rajaram M, Malik A, Mohanty Mohapatra M, et al. Comparison of clinical, radiological and laboratory parameters between elderly and young patient with newly diagnosed smear positive pulmonary tuberculosis: a hospital-based cross sectional study. Cureus. 2020;12(5):e8319. doi:10.7759/cureus.8319
   PubMed Web of Science ®Google Scholar
• Zhao FZ, Levy MH, Wen S. Sputum microscopy results at two and three months predict outcome of tuberculosis treatment. Int J Tuberc Lung Dis. 1997;1(6):570–572.
   PubMed Web of Science ®Google Scholar
• Nehal TS, Kothandapani SK. Tuberculosis in elderly: the Indian perspective. Medip Acad. 2018. doi:10.18203/2349-3933.ijam20183133
   Google Scholar
• Ananthakrishnan R, Kumar K, Ganesh M, et al. The profile and treatment outcomes of the older (aged 60 years and above) tuberculosis patients in Tamilnadu, South India. PLoS One. 2013;8(7):e67288. doi:10.1371/journal.pone.0067288
   PubMed Web of Science ®Google Scholar
• Joshi JL, Devi S, Mohan V, et al. Clinico-radiological variability of pulmonary tuberculosis in young patients as compared to elder patients prior to RNTCP and after 18 years RNTCP. Int J Res Med Sci. 2018;6(6):2116–2126. doi:10.18203/2320-6012.ijrms20182299
   Google Scholar
• Arora VK, Singla N, Sarin R. Profile of geriatric patients under DOTS in revised national tuberculosis control programme. Indian J Chest Dis Allied Sci. 2003;45(4):231–235.
   PubMedGoogle Scholar
• Davies PD. Tuberculosis in the elderly. Epidemiology and optimal management. Drugs Aging. 1996;8(6):436–444. doi:10.2165/00002512-199608060-00005
   PubMed Web of Science ®Google Scholar
• Fan L, Xiong KL, Xiao HP. Historic review of anti-tuberculosis chemotherapy during seventy years of the People’s Republic of China. Chin J Antituberculosis. 2019;41(11):1145–1148.
   Google Scholar
• Udomsinprasert W, Sakuntasri W, Jittikoon J, et al. Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury. Emerg Microbes Infect. 2021;10(1):1862–1872. PMID: 34467830; PMCID: PMC8451674. doi:10.1080/22221751.2021.1976079
   PubMed Web of Science ®Google Scholar
• Zhong T, Fan Y, Dong XL, et al. An investigation of the risk factors associated with anti-tuberculosis drug-induced liver injury or abnormal liver functioning in 757 patients with pulmonary tuberculosis. Front Pharmacol. 2021;12:708522. PMID: 34819852; PMCID: PMC8606396. doi:10.3389/fphar.2021.708522
   PubMed Web of Science ®Google Scholar
• Senior Department of Tuberculosis/Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment/Institute for Tuberculosis Research of the 8th Medical Center of Chinese PLA General Hospital. Expert consensus on immune function assessment and immunotherapy in patients with active tuberculosis (2021 Edition). Chin J Antituberculosis. 2022;44(1):9–27.
   Google Scholar
• Guo J, Liu ZD, Zhang ZJ. Effects of Kanglao mixture on serum VEGF level in MDR-FTB patients. Chin J Trad Med Sci Technol. 2016;23(2):153–154.
   Google Scholar
• Guo J, Liu ZD, Zhang ZJ. Effects of Kanglao mixture on Th17/Treg cells in patients with multidrug-resistant tuberculosis. Chin J Trad Med Sci Technol. 2019;26(7):491–495.
   Google Scholar
• Guo J, Liu ZD, Zhang ZJ, et al. Efficacy and influencing factors of treatment for multidrug-resistant tuberculosis in Lishui. Prev Med. 2018;30(10):987–991.
   Google Scholar